Latest Breaking News On - Janin edelkamp - Page 1 : comparemela.com

Bristol Myers Squibb Announces New Sotyktu™ (deucravacitinib) Long-Term Data Showing Clinical Effica

Results add to the growing body of evidence and reinforce the efficacy profile of Sotyktu, a once-daily, oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor for the treatment of moderate-to-severe plaque psoriasisNew analysis to be presented at the 2022 European Academy of Dermatology and Venereology Cong.

New yorkUnited statesCity ofUnited kingdomJun shenJanin edelkampJiyoon choiMark lebwohlRichardb warrenYayoi tadaNeil kormanMayumi komineZhang jianzhongArthur kavanaughBristol myers squibbJashinj wu

Bristol Myers Squibb Data at the EADV 30th Anniversary Congress Highlight the Growing Body of Evidence on Deucravacitinib and Scientific Advancements for Patients with Serious Dermatologic Diseases

Bristol Myers Squibb Data at the EADV 30th Anniversary Congress Highlight the Growing Body of Evidence on Deucravacitinib and Scientific Advancements for Patients with Serious Dermatologic Diseases
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.

New south walesUnited statesApril armstrongJoe zhuoJanin edelkampMelinda gooderhamRichard warrenJenny xieMary beth harlerRichardb warrenFarah toublanNeil kormanAnjaneya chimalakondaBristol myers squibbJashinj wuJosephf merola